Skip to main content
Premium Trial:

Request an Annual Quote

CuraGen’s Board Agrees To Two-for-One Stock Split

Premium

NEW HAVEN, Conn.--CuraGen announced that its Board of Directors has approved a two-for-one stock split of the company’s common stock on March 30. At that time, stockholders will receive one additional share of the stock for every share each owned at the close of business on March 15. The stock will begin trading on a split-adjusted basis on March 31.

Filed under

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.